BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
The seed round was co-led by UI Investissement (via the Pertinence Invest 2 Fund, advised by Mérieux Equity Partners), Elaia and GO Capital, with participation from one major ophthalmology player, Unither Pharmaceuticals […]
Boston Biotechnology Summit winner, Gold first prize
BIOPHTA received the Gold medal of the Boston Biotechnology summit from the hands of the summit director, Dr Shahin GHARAKHANIAN. BIOPHTA stood out amongst a global panel of prestigious biotech startups and […]
Winner of the Innov’UP leader PIA program, Île de France region
Innov’UP leader is a Deep Tech startup competition which is part of the French national plan PIA4 (programme d’investissements d’avenir) and is co-funded by the region Île-de-France.
Positive feedback from the US-FDA following a pre-IND meeting
BIOPHTA was invited to an official hearing by the FDA in order to present the development roadmap of its initial product as well as the planned regulatory pathway. The FDA has validated […]
Winner of the 23rd i-Lab National innovation competition of the French Government
i-Lab is a highly selective national startup competition rewarding early-stage Deep Tech projects. This very prestigious trophy also comes with a prize of €350,000 in subsidies to support the initial R&D phases […]
Closing of a pre-Seed financing round and capital increase of €550,000
BIOPHTA closes its very first round of financing with a group of 9 business angels. This syndicate of investors is mainly composed of healthcare professionals as well as pharma industry experts. Beyond […]
Selected to join Voisin Consulting Life Science’s Neighborhood program
BIOPHTA integrates the 12-months program from the life science innovation center from Voisin Consulting Life Sciences, the leading global regulatory affairs firm.
Selected to join Wilco’s accelerator program
WILCO supports entrepreneurs who are revolutionizing the healthcare sector with projects that provide deeptech solutions for improving patient care and facilitating healthcare professionals’ practice.
Winner of the Healthy Longevity Challenge from the US Academy of Medicine
BIOPHTA has been awarded by the Healthy Longevity Global Competition organized by the American Academy of Medicine.
Winner of EIT Health’s pan-European Headstart competition
BIOPHTA has been awarded by the Headstart program and granted a €50,000 money prize. This program is funded by EIT Health, which is a body of European Union.